Simplex Trading’s IGM Biosciences IGMS Stock Holding History

Simplex Trading’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-561	Closed	-$1.04K	–	8998
2024 Q4	$3K	Buy	561 +157	+39%	+$1.86K	﹤0.01%	7881
2024 Q3	$6K	Sell	404 -355	-47%	-$3.89K	﹤0.01%	7518
2024 Q2	$5K	Buy	+759	New	+$6.5K	﹤0.01%	7871
2024 Q1	–	Sell	-1,810	Closed	-$15K	–	9296
2023 Q4	$15K	Buy	+1,810	New	+$10.5K	﹤0.01%	7137
2023 Q1	–	Sell	-11,383	Closed	-$235K	–	9504
2022 Q4	$193K	Sell	11,383 -20,385	-64%	-$408K	﹤0.01%	4269
2022 Q3	$722K	Buy	31,768 +3,126	+11%	+$63.1K	﹤0.01%	3039
2022 Q2	$516K	Buy	+28,642	New	+$511K	﹤0.01%	3400
2020 Q4	–	Sell	-92	Closed	-$6.47K	–	8658
2020 Q3	$6K	Buy	+92	New	+$5.45K	﹤0.01%	7030

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's IGMS Position: Q1 2025 in Review

Simplex Trading sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 561 shares — an estimated $1.04K sold.

Simplex Trading first reported a position in IGMS in Q3 2020 and held it in 8 quarters. The position peaked at $722K in Q3 2022. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

Simplex Trading reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
Simplex Trading sold 561 IGM Biosciences shares in Q1 2025, an estimated $1.04K.
Simplex Trading first reported a position in IGM Biosciences in Q3 2020 and held it in 8 quarters.
Simplex Trading's IGM Biosciences position peaked at $722K in Q3 2022.
79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.